1. Stocks
    2. /
  2. Mesoblast Limited (ASX: MSB)
    3. /

Mesoblast Limited (ASX: MSB) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Mesoblast Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • Mesoblast Limited (ASX: MSB)
    Latest News

    Shot of a young businesswoman looking stressed out while working in an office.
    Share Fallers

    Why Domain, Mesoblast, Pro Medicus, and Tuas shares are tumbling today

    | James Mickleboro

    These shares are having a tough time on Thursday. But why?

    Read more »

    Scientists working in the laboratory and examining results.
    Healthcare Shares

    2 ASX 200 biotech stocks announcing big news today

    | James Mickleboro

    Let's see how the market has responded to these announcements.

    Read more »

    a doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.
    Healthcare Shares

    Bell Potter names the best ASX healthcare stocks to buy now

    | James Mickleboro

    The broker has good things to say about these stocks.

    Read more »

    A neon sign says 'Top Ten'.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    The ASX bounced back with a vengeance today.

    Read more »

    Person pretends to types on laptop drawn in sand.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    It was a woeful Wednesday for ASX investors today.

    Read more »

    Lines of codes and graphs in the background with woman looking at laptop trying to understand the data.
    Share Fallers

    Why Appen, Mesoblast, Rio Tinto, and Woodside shares are falling today

    | James Mickleboro

    These shares are falling more than most on Thursday. But why?

    Read more »

    A young woman holds her hand to her mouth in surprise as she reads something on her laptop.
    Healthcare Shares

    Why Mesoblast shares could still be dirt cheap even after 700% gain

    | James Mickleboro

    This biotech has been on fire but the gains may not be over yet according to Bell Potter.

    Read more »

    Doctor doing a telemedicine using laptop at a medical clinic
    Healthcare Shares

    Up 810% in a year, the Mesoblast share price is surging again on Monday. Here's why

    | Bernd Struben

    Investors are piling into Mesoblast shares on Monday. But why?

    Read more »

    Doctor doing a telemedicine using laptop at a medical clinic
    Healthcare Shares

    Mesoblast share price rips 12% on financial and operational updates

    | Bronwyn Allen

    Mesoblast has set a price for its recently-approved flagship drug, which will go to market over the next few weeks.

    Read more »

    a man sits at his desk wearing a business shirt and tie and has a hearty laugh at something on his mobile phone.
    Broker Notes

    5 ASX All Ords shares upgraded to 'strong buy' consensus ratings

    | Bronwyn Allen

    Brokers upgraded their ratings on these ASX All Ords stocks last month.

    Read more »

    A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
    Share Fallers

    Why Block, Canyon, Fisher & Paykel Healthcare, and Mesoblast shares are falling today

    | James Mickleboro

    These shares are having a tough time on hump day. What's going on?

    Read more »

    Boys making faces and flexing.
    Share Gainers

    3 ASX All Ords stocks smashing the benchmark this week

    | Bernd Struben

    Investors sent these three ASX All Ords stocks soaring this week. But why?

    Read more »

    Frequently Asked Questions

    No, Mesoblast does not pay shareholder dividends at this time.

    Yes, Mesoblast is listed on the ASX and the US Nasdaq under the ticker code NASDAQ: MESO.

    Mesoblast Ltd listed on the ASX on 16 December 2004.

    MSB ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Mesoblast Limited

    Mesoblast Ltd (ASX: MSB) is a clinical-stage biotechnology company. It develops and commercialises allogeneic cellular medicines to treat complex diseases resistant to conventional standards of care.

    Its portfolio of Phase 3 product candidates includes its flagship remestemcel-L for the treatment of steroid-refractory acute graft versus host disease (SR-aGVHD) as well as moderate to severe acute respiratory distress syndrome (ARDS). Its other candidates include REVASCOR® for advanced chronic heart failure and MPC-06-ID for chronic low back pain due to degenerative disc disease. These cell therapy candidates are towards the latter stages of their clinical trial pipelines. 

    Mesoblast has locations in Australia, the United States, and Singapore and is dual-listed on the ASX and the US Nasdaq (NASDAQ: MESO).

    Profile

    since

    Note